{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Mortalité périnatale : Questions médicales les plus fréquentes",
"headline": "Mortalité périnatale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Mortalité périnatale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-02",
"dateModified": "2025-03-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Mortalité périnatale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Mortalité infantile",
"url": "https://questionsmedicales.fr/mesh/D007226",
"about": {
"@type": "MedicalCondition",
"name": "Mortalité infantile",
"code": {
"@type": "MedicalCode",
"code": "D007226",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.308.985.550.475"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Mortalité périnatale",
"alternateName": "Perinatal Mortality",
"code": {
"@type": "MedicalCode",
"code": "D054238",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Keelin O'Donoghue",
"url": "https://questionsmedicales.fr/author/Keelin%20O%27Donoghue",
"affiliation": {
"@type": "Organization",
"name": "Pregnancy Loss Research Group (PLRG), Department of Obstetrics and Gynaecology, University College Cork, Cork, Ireland."
}
},
{
"@type": "Person",
"name": "Richard Greene",
"url": "https://questionsmedicales.fr/author/Richard%20Greene",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynaecology, School of Medicine and Health, University College Cork, Cork, Ireland."
}
},
{
"@type": "Person",
"name": "Sara Leitao",
"url": "https://questionsmedicales.fr/author/Sara%20Leitao",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynaecology, School of Medicine and Health, University College Cork, Cork, Ireland."
}
},
{
"@type": "Person",
"name": "K S Joseph",
"url": "https://questionsmedicales.fr/author/K%20S%20Joseph",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynaecology, School of Population and Public Health, University of British Columbia and the Children's and Women's Hospital and Health Centre of British Columbia, Vancouver, British Columbia, Canada."
}
},
{
"@type": "Person",
"name": "Alfred Körblein",
"url": "https://questionsmedicales.fr/author/Alfred%20K%C3%B6rblein",
"affiliation": {
"@type": "Organization",
"name": "Untere Söldnersgasse 8, D-90403, Nürnberg, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Platelet transfusion and mortality in patients with sepsis-induced thrombocytopenia: A propensity score matching analysis.",
"datePublished": "2022-07-19",
"url": "https://questionsmedicales.fr/article/35851699",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/vox.13335"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prediction of Mid-term Platelet Transfusion in Stable Trauma Patients Using Rotational Thromboelastometry.",
"datePublished": "2023-09-04",
"url": "https://questionsmedicales.fr/article/37665288",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3343/alm.2024.44.1.74"
}
},
{
"@type": "ScholarlyArticle",
"name": "Therapeutic efficacy of platelet transfusion treated with amotosalen/UVA pathogen inactivation technology (INTERCEPT",
"datePublished": "2023-02-10",
"url": "https://questionsmedicales.fr/article/36795348",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2450/2023.0143-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intensity of endogenous thrombocytopenia after autologous stem cell transplantation in patients prophylactically transfused with platelets.",
"datePublished": "2023-05-22",
"url": "https://questionsmedicales.fr/article/37218336",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/vox.13445"
}
},
{
"@type": "ScholarlyArticle",
"name": "Associations between ABO non-identical platelet transfusions and patient outcomes-A multicenter retrospective analysis.",
"datePublished": "2023-03-30",
"url": "https://questionsmedicales.fr/article/36994786",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/trf.17319"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Méthodes épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D004812"
},
{
"@type": "ListItem",
"position": 5,
"name": "Collecte de données",
"item": "https://questionsmedicales.fr/mesh/D003625"
},
{
"@type": "ListItem",
"position": 6,
"name": "Registre civil",
"item": "https://questionsmedicales.fr/mesh/D014798"
},
{
"@type": "ListItem",
"position": 7,
"name": "Mortalité",
"item": "https://questionsmedicales.fr/mesh/D009026"
},
{
"@type": "ListItem",
"position": 8,
"name": "Mortalité infantile",
"item": "https://questionsmedicales.fr/mesh/D007226"
},
{
"@type": "ListItem",
"position": 9,
"name": "Mortalité périnatale",
"item": "https://questionsmedicales.fr/mesh/D054238"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Mortalité périnatale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Mortalité périnatale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Mortalité périnatale",
"description": "Comment diagnostiquer la mortalité périnatale ?\nQuels examens sont nécessaires pour évaluer la mortalité périnatale ?\nQuels indicateurs sont utilisés pour évaluer la mortalité périnatale ?\nComment les données de mortalité périnatale sont-elles collectées ?\nQuel rôle joue l'autopsie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Mortalité périnatale",
"description": "Quels sont les symptômes associés à la mortalité périnatale ?\nComment reconnaître un décès fœtal in utero ?\nQuels signes peuvent indiquer une complication périnatale ?\nQuels sont les signes cliniques d'un nouveau-né décédé ?\nComment évaluer la santé d'un nouveau-né à risque ?",
"url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Mortalité périnatale",
"description": "Quelles mesures préventives peuvent réduire la mortalité périnatale ?\nComment l'éducation prénatale aide-t-elle à prévenir la mortalité périnatale ?\nQuel rôle joue le suivi médical dans la prévention ?\nComment la vaccination peut-elle influencer la mortalité périnatale ?\nPourquoi est-il important de gérer les maladies maternelles ?",
"url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Mortalité périnatale",
"description": "Quels traitements sont disponibles pour prévenir la mortalité périnatale ?\nComment traiter une détresse néonatale ?\nQuels médicaments peuvent réduire les risques périnataux ?\nQuel rôle joue la césarienne dans la mortalité périnatale ?\nComment gérer les grossesses à risque ?",
"url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Mortalité périnatale",
"description": "Quelles sont les complications courantes liées à la mortalité périnatale ?\nComment les anomalies congénitales affectent-elles la mortalité périnatale ?\nQuel impact a l'hypoxie sur le fœtus ?\nComment les infections maternelles influencent-elles la mortalité périnatale ?\nQuelles sont les conséquences d'une prématurité sur la mortalité périnatale ?",
"url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Mortalité périnatale",
"description": "Quels sont les principaux facteurs de risque de mortalité périnatale ?\nComment le tabagisme affecte-t-il la mortalité périnatale ?\nQuel rôle joue la nutrition maternelle dans la mortalité périnatale ?\nComment les antécédents médicaux influencent-ils les risques ?\nQuel impact a l'accès aux soins prénatals sur la mortalité périnatale ?",
"url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la mortalité périnatale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'analyse des certificats de décès et des dossiers médicaux."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour évaluer la mortalité périnatale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échographies, des analyses sanguines et des examens post-mortem peuvent être requis."
}
},
{
"@type": "Question",
"name": "Quels indicateurs sont utilisés pour évaluer la mortalité périnatale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les taux de mortalité, les causes de décès et les facteurs de risque sont des indicateurs clés."
}
},
{
"@type": "Question",
"name": "Comment les données de mortalité périnatale sont-elles collectées ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont collectées par les systèmes de santé publique et les registres de décès."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'autopsie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'autopsie peut aider à déterminer la cause de décès et à identifier des anomalies."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes associés à la mortalité périnatale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'absence de battements cardiaques fœtaux et des signes de détresse néonatale."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un décès fœtal in utero ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'absence de mouvements fœtaux et l'absence de battements cardiaques à l'échographie sont des signes."
}
},
{
"@type": "Question",
"name": "Quels signes peuvent indiquer une complication périnatale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements vaginaux, des douleurs abdominales ou une diminution des mouvements fœtaux peuvent indiquer des complications."
}
},
{
"@type": "Question",
"name": "Quels sont les signes cliniques d'un nouveau-né décédé ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une pâleur, une rigidité cadavérique et l'absence de respiration."
}
},
{
"@type": "Question",
"name": "Comment évaluer la santé d'un nouveau-né à risque ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation inclut l'examen physique, la surveillance des signes vitaux et des tests de laboratoire."
}
},
{
"@type": "Question",
"name": "Quelles mesures préventives peuvent réduire la mortalité périnatale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins prénatals réguliers, une nutrition adéquate et l'évitement de substances nocives sont essentiels."
}
},
{
"@type": "Question",
"name": "Comment l'éducation prénatale aide-t-elle à prévenir la mortalité périnatale ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation prénatale informe les parents sur les soins et les signes de complications."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le suivi médical dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier permet de détecter et de traiter les problèmes de santé précocement."
}
},
{
"@type": "Question",
"name": "Comment la vaccination peut-elle influencer la mortalité périnatale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination des mères peut protéger les nouveau-nés contre certaines infections."
}
},
{
"@type": "Question",
"name": "Pourquoi est-il important de gérer les maladies maternelles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des maladies maternelles réduit les risques de complications pour le fœtus et le nouveau-né."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour prévenir la mortalité périnatale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des soins prénatals appropriés et la gestion des complications."
}
},
{
"@type": "Question",
"name": "Comment traiter une détresse néonatale ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure l'assistance respiratoire, la réanimation et des soins intensifs."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent réduire les risques périnataux ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les corticostéroïdes peuvent aider à maturer les poumons fœtaux."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la césarienne dans la mortalité périnatale ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La césarienne peut être nécessaire pour éviter des complications lors de l'accouchement."
}
},
{
"@type": "Question",
"name": "Comment gérer les grossesses à risque ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance accrue et des interventions médicales précoces sont essentielles pour les grossesses à risque."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications courantes liées à la mortalité périnatale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'hypoxie, les infections et les anomalies congénitales."
}
},
{
"@type": "Question",
"name": "Comment les anomalies congénitales affectent-elles la mortalité périnatale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anomalies congénitales peuvent entraîner des décès fœtaux ou néonatals en raison de malformations graves."
}
},
{
"@type": "Question",
"name": "Quel impact a l'hypoxie sur le fœtus ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypoxie peut provoquer des lésions cérébrales et augmenter le risque de mortalité périnatale."
}
},
{
"@type": "Question",
"name": "Comment les infections maternelles influencent-elles la mortalité périnatale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections maternelles peuvent se transmettre au fœtus et entraîner des complications graves."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une prématurité sur la mortalité périnatale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prématurité augmente le risque de complications et de décès néonatal en raison d'organes immatures."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de mortalité périnatale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge maternel avancé, les maladies chroniques et les grossesses multiples."
}
},
{
"@type": "Question",
"name": "Comment le tabagisme affecte-t-il la mortalité périnatale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme augmente le risque de complications et de décès fœtal en raison de l'hypoxie."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la nutrition maternelle dans la mortalité périnatale ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise nutrition peut entraîner des complications comme la prématurité et le faible poids à la naissance."
}
},
{
"@type": "Question",
"name": "Comment les antécédents médicaux influencent-ils les risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de complications obstétricales augmentent le risque de mortalité périnatale."
}
},
{
"@type": "Question",
"name": "Quel impact a l'accès aux soins prénatals sur la mortalité périnatale ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un accès limité aux soins prénatals augmente le risque de complications et de décès."
}
}
]
}
]
}
Thrombocytopenia is common among sepsis patients. Platelet transfusions are frequently administered to increase platelet counts, but their clinical impacts remain unclear in sepsis-induced thrombocyto...
The study was based on the Medical Information Mart for Intensive Care (MIMIC) III database. Septic patients with severe thrombocytopenia (a platelet count ≤ 50/nl) were included in the study and were...
A total of 1733 patients were included: 296 patients were included in the PT group and 1437 patients were included in the NPT group. After propensity score matching, 296 paired patients constituted ea...
The propensity score-matched analysis showed that platelet transfusion was associated with increased in-hospital mortality in septic patients with severe thrombocytopenia (a platelet count ≤ 50/nl). H...
Rotational thromboelastometry (ROTEM; TEM International GmbH, Munich, Germany) is a global coagulation test that guides evidence-based platelet transfusion in trauma patients. We evaluated ROTEM param...
Maximum clot firmness and clot amplitudes after 5, 10, and 15 mins (A5, A10, and A15, respectively) of fibrin-specific ROTEM (FIBTEM) and extrinsically activated ROTEM (EXTEM) were retrospectively col...
The areas under the curve for FIBTEM, EXTEM, and PLTEM predicting platelet concentrate transfusion of >12 U at mid-term were 0.915-0.923, 0.878-0.896, and 0.551-0.735, respectively. FIBTEM and EXTEM p...
FIBTEM and EXTEM can reliably predict mid-term platelet transfusion in trauma patients. FIBTEM, EXTEM, and PLTEM parameters correlate with conventional coagulation tests (platelets and fibrinogen)....
The INTERCEPT...
After comparing the transfusion efficiency between pathogen-reduced platelets (PR_PLT) and untreated platelet products (U_PLT), our single-center observational study assessed the effectiveness of PR_P...
Whereas the transfused doses tended to be higher in the PR_PLT group compared to U_PLT, there was a significant difference in intertransfusion interval (ITI) and 24h_CCI. In prophylactic transfusions,...
These results, which must be confirmed by prospective studies, indicate the need for vigilance regarding the quantity and quality of PR_PLT products used to treat patients at risk of bleeding crisis. ...
Large clinical trials have demonstrated that some patient groups with hypoproliferative thrombocytopenia benefit from prophylactic platelet transfusions, while in others, a therapeutic transfusion reg...
Multiple myeloma (n = 22) patients received high-dose melphalan alone (HDMA); lymphoma patients (n = 15) received BEAM or TEAM (B/TEAM) conditioning. Patients with a total platelet count <10 G/L recei...
Post-transplantation B/TEAM patients received their first platelet transfusion on average 3 days earlier than HDMA patients (p < 0.001) and required about twofold more platelet concentrates (p < 0.001...
Monitoring endogenous platelet counts detects the direct effects of myelosuppressive chemotherapies on platelet regeneration. This approach may help to develop a platelet transfusion regimen tailored ...
Due to platelet availability limitations, platelet units ABO mismatched to recipients are often transfused. However, since platelets express ABO antigens and are collected in plasma which may contain ...
The large 4-year publicly available Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) database was used to investigate patient outcomes associated with ABO non-identical platelet transf...
Following adjustment for possible confounding factors, no statistically significant association between ABO non-identical platelet transfusion and increased risk of mortality was observed in the overa...
We suggest that prospective studies are needed to determine if specific patient populations would benefit from receiving ABO identical platelet units. Our findings indicate that ABO-identical platelet...
Venous thromboembolism (VTE) in patients with thrombocytopenia represents a complex management challenge....
To describe practice, document outcomes, and compare management to national guidelines....
We present a prospective multicenter cohort of 105 patients with hematological cancer, VTE within 28 days, and platelets <50 × 10...
Median age was 64 and median initial platelet count 28 × 10...
This data set demonstrates the heterogeneity of approaches used in patients presenting with severe thrombocytopenia and acute thrombosis and confirms the high rates of bleeding in this cohort with thr...
Platelets are a key component of massive transfusion in treating actively bleeding patients. While optimized for prophylactic transfusions, the effectiveness of the current standard room temperature s...
RPs or CPs were combined with RBCs and plasma in a 1:1:1 volume ratio to make transfusion packages. Whole blood was collected and then either diluted to 20% hematocrit or mixed with tPA (8.8 μg/ml). B...
Both transfusion packages restored the clot characteristics of hemodiluted or hyperfibrinolytic whole blood. Specifically, only transfusion packages made with CPs significantly reduced the maximum clo...
Transfusion packages containing cold-stored platelets may be able to restore the blood hemostatic profile of bleeding patients. In addition, transfusion packages made from CPs may provide additional b...
The formation of alloantibodies directed against class I human leukocyte antigens (HLA) continues to be a clinically challenging complication after platelet transfusions, which can lead to platelet re...
To characterize the Fc glycosylation profile of anti-HLA class I antibodies formed after platelet transfusion and to investigate its effect on clinical outcome....
We screened and captured anti-HLA class I antibodies (anti-HLA A2, anti-HLA A24, and anti-HLA B7) developed after platelet transfusions in hemato-oncology patients, who were included in the PREPAReS T...
The glycosylation profile of anti-HLA antibodies was highly variable between patients. In general, Fc galactosylation and sialylation levels were elevated compared to total plasma IgG, which correlate...
These differences in composition of anti-HLA Fc-glycosylation profiles could potentially explain the variation in clinical severity between patients....
Thrombocytopenia, hemorrhage and platelet transfusion are common in patients supported with venoarterial extracorporeal membrane oxygenation (VA ECMO). However, current literature is limited to small ...
This was a sub-study of a multicenter (N = 16) study on transfusion practices in patients on VA ECMO, in which a retrospective cohort (Jan-2018-Jul-2019) focusing on platelets was selected. The primar...
Of the 419 patients included, median platelet count at admission was 179·10...
Thrombocytopenia has a higher occurrence than is currently recognized. Severe thrombocytopenia is strongly associated with platelet transfusion. Future studies should focus on the etiology of severe t...
This study was registered at the Netherlands Trial Registry at February 26th, 2020 with number NL8413 and can currently be found at https://trialsearch.who.int/Trial2.aspx?TrialID=NL8413....
Patients with hematological disorders and severe thrombocytopenia require extensive and iterative platelet transfusion support. In these patients, platelet transfusion refractoriness represents a seri...